0001179110-11-008881.txt : 20110531
0001179110-11-008881.hdr.sgml : 20110530
20110531163618
ACCESSION NUMBER: 0001179110-11-008881
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110527
FILED AS OF DATE: 20110531
DATE AS OF CHANGE: 20110531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BUCHEN DAVID A
CENTRAL INDEX KEY: 0001241751
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13305
FILM NUMBER: 11881767
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WATSON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000884629
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 953872914
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: MORRIS CORPORATE CENTER III
STREET 2: 400 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 9092701400
MAIL ADDRESS:
STREET 1: MORRIS CORPORATE CENTER III
STREET 2: 400 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
4
1
edgar.xml
FORM 4 -
X0303
4
2011-05-27
0
0000884629
WATSON PHARMACEUTICALS INC
WPI
0001241751
BUCHEN DAVID A
MORRIS CORPORATE CENTER III
400 INTERPACE PKWY
PARSIPPANY
NJ
07054
0
1
0
0
Exec VP,General Counsel & Sec.
Common Stock, par value $0.0033
2011-05-27
4
M
0
1400
54.48
A
67972
D
Common Stock, par value $0.0033
2011-05-27
4
M
0
5600
54.48
A
73572
D
Common Stock, par value $0.0033
2011-05-27
4
S
0
7000
64.10
D
66572
D
Non-Qualified Options to Purchase Common Stock
54.48
2011-05-27
4
M
0
1400
0
D
2005-12-15
2011-08-23
Common Stock, par value $0.0033
1400
0
D
Non-Qualified Options to Purchase Common Stock
54.48
2011-05-27
4
M
0
5600
0
D
2005-08-23
2011-08-23
Common Stock, par value $0.0033
5600
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.1 to $64.11, inclusive. The reporting person undertakes to provide to Watson Pharmaceuticals, Inc., any security holder of Watson Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.
/s/DAVID A. BUCHEN
2011-05-31